Retatrutide 20mg – triple GIP/GLP-1/glucagon receptor triagonist (CAS 2381089-83-2, ~4,681 Da) studied in preclinical metabolic research for coordinated incretin signalling and energy homeostasis regulation. ≥98% purity.
Retatrutide 20mg – triple GIP/GLP-1/glucagon receptor triagonist (CAS 2381089-83-2, ~4,681 Da) studied in preclinical metabolic research for coordinated incretin signalling and energy homeostasis regulation. ≥98% purity.
